1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NIKI BIOSOLUTIONS INC.
Niki BioSolutions Inc.
XNAS: NIKI
Download real time
4.00-0.32(-7.41%)
New 52W Low today
8,063
XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Board Meeting
The next board meeting for Niki BioSolutions Inc is on 16 Oct 2026 for the purpose of Niki BioSolutions Inc Second Quarter Earnings Results for 2026See details

Niki BioSolutions Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Niki BioSolutions Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue Niki BioSolutions Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • NEUTRAL

    Quarterly Net Profit Niki BioSolutions Inc Jun-2026 Quarterly Net Profit is $0 Million which is growth of 0% YoY.

Niki BioSolutions Inc., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Dec '25Sep '25Jun '25Dec '24Sep '24Jun '24Dec '23Jun '23Dec '22Jun '22Dec '21Jun '21
Operating Rev.
---------
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
-0.80.6--0.60.7--
Operating Profit
--0.8-0.6-0.6-0.7--
⌄
--0-0--0-0-------
Profit Before Tax
--0.3-0.6--0.8-0.7-------
Tax
-------------
⌄
--0.3-0.6--0.9-0.7-------
Diluted NI Avail to Com Stockholders Ann.
--0.3-0.6--0.9-0.7-------
Basic EPS
--0.4-0.9--1.6-1.2-------
Diluted EPS After ExtraOrdinary
--1.1-0.9-0.2-1.2-------
Number Of Shares End
-0.80.7-0.60.6--5.23.63.63.63.6
Net Income Continuing Discontinued Operations
--0.3-0.6--0.9-0.7-------
Normalized Income
--0.3-0.6-0.2-0.7-------
Interest Income
-------------
Interest
--0--0-------
Net Interest Income
--0-0--0-0-------
EBIT
--0.3-0.6--0.7-0.7-------
EBITDA
--0.3-0.6--0.7-0.7-------
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
-------------
Profit From Continuing Operations
-------------
Normalized EBITDA
--1.4-0.6-1.3-0.7-------
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Niki BioSolutions Inc competitor comparison and performance snapshot within industry

Niki BioSolutions Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Annual Revenue Niki BioSolutions Inc Annual Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Annual Net Profit Niki BioSolutions Inc Annual Net Profit is $-1 Million which is growth of 68.1% YoY.

Niki BioSolutions Inc., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17
⌄
-
-
 0.41.31.50.90.50.4-
Cost Of Rev. Ann.
-
-
 0.41.21.510.80.3-
Gross Profit Ann.
-
-
 00.10.1-0.1-0.30.1-
Operating Exp. Ann.
-53.2%
-38.3%
 1.8310.717.619.320.217.910.4
Operating Profit Ann.
-
-
 -1.8-3-10.7-17.5-19.2-20.3-18.2-10.3
⌄
-
-
 -0.1-0.2-0.10.2-0.1-0.2-3.7-4.5-
Other Exp. Ann.
-55.8%
-54.4%
 0.5-16.55.8-7.825.41.8-0.4-
PBT Ann.
-
-
 -1.4-4.2-4.3-11.5-27.14.9-20.1-15.1-
Tax Ann.
-
-
 ---------
⌄
-
-
 -1.4-4.3-2.8-9.8-25.16.3-18.7-14.8-
Diluted NI Avail to Com Stockholders Ann.
-
-
 -1.4-4.3-2.8-9.8-25.16.3-18.7-14.8-
EPS Ann.
-
-
 -1.9-7.8-6.2-27.5-7120-64-53-
Diluted EPS Ann.
-
-
 -1.9-7.8-6.2-27.5-7120-64-53-
Number Of Shares End
-39.4%
-25.1%
 0.80.6-3.63.63.42.92.9-
Total Exp. Ann.
-54.3%
-38.9%
 1.8311.218.820.821.218.710.7-
Net Income Continuing Discontinued Operations Ann.
-
-
 -1.4-4.3-2.8-9.8-25.17.1-18.7-14.8-
Normalized Income Ann.
-
-
 -1.9-1.5-8.5-15.1-17.5-18.1-20-14.8-
Interest Income Ann.
-
-
 ---0.2-----
Interest Ann.
-
-
 ----0.10.2---
EBITDA Ann.
-
-
 -1.3-3.7-3.1-10.5-25.86.5-15.1-10-
Reconciled Cost Of Rev. Ann.
-
-
 0.40.20.500.80.3-
Reconciled Depr. Ann.
-37%
-25.4%
 0.31.11.21.21.31.30.7-
Profit From Continuing Operations Ann.
-
-
 -1.4-4.2-4.3-11.5-27.14.9-20.1-15.1-
Normalized EBITDA Ann.
-
-
 -2.4-1.7-15.9-21.8-17.9-18.5-18.4-9.3-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
-40%
2Y CAGR
-59%
3Y CAGR
-53.2%
5Y CAGR
-38.3%
7Y CAGR
-22.2%
Operating Expenses Annual Cr is falling faster than historical averages.

Niki BioSolutions Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Niki BioSolutions Inc Dec-2025 Total Shareholders Fund is $23 Million which is growth of 9.6% YoY.

  • POSITIVE

    Total Assets Niki BioSolutions Inc Dec-2025 Total Assets is $19 Million which is growth of 15.9% YoY.

Niki BioSolutions Inc., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17
⌄
-3.6%
-15.8%
18.716.120.620.921.944.22445.131.6
⌄
-27.8%
-4.3%
4.94.45.3134.46.19.112.31.3
⌄
13.9%
-11.1%
23.221.124.915.723.641.816.433.130.2
Total Capitalization Ann.
12.7%
-11.9%
23.221.127.916.223.643.822.733.130.2
Tangible Assets Ann.
15.6%
-10.7%
23.221.124.71522.740.915.131.728.8
Working Capital Ann.
-
-
-1-3.40.4-5.48.329.85.416.519
Invested Capital Ann.
6.2%
-9.5%
26.624.427.922.223.643.822.743.230.7
Tangible Book Value Ann.
15.6%
-10.7%
23.221.124.71522.740.915.131.728.8
Borrowings Ann.
-21%
4.7%
3.43.43.36.90.22.76.510.30.5
Net Debt Ann.
-
-
-2.41.14.6--1.1--
Share Issued Ann.
26%
21.7%
0.80.60.50.40.40.30.30.30.2
Number Of Shares End
-39.4%
-25.1%
0.80.6-3.63.63.42.92.9-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
16.1%
2Y CAGR
-4.7%
3Y CAGR
-3.6%
5Y CAGR
-15.8%
7Y CAGR
-11.8%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
7%
2Y CAGR
48%
3Y CAGR
-28.3%
5Y CAGR
3.4%
7Y CAGR
-13%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
10%
2Y CAGR
-3.5%
3Y CAGR
13.9%
5Y CAGR
-11.1%
7Y CAGR
-5%
Total ShareHolders Funds Annual growth is stable compared to historical averages.

Niki BioSolutions Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Niki BioSolutions Inc Book Value Per Share is $27 which is growth of -9.4% YoY.

  • NEUTRAL

    ROE Niki BioSolutions Inc ROE is 0% which is growth of 0% YoY.

Niki BioSolutions Inc., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17
RoA Ann. %
-
-
--23.21%-13.61%-45.82%-75.75%18.51%-54.14%-38.71%-
ROE Ann. %
-
-
--18.56%-13.93%-49.85%-76.55%21.69%-75.54%-46.82%-
ROIC %
-
-
---------
OPM Ann. %
-
-
---2,486.03%-1,351.13%-1,245.80%-2,224.39%-3,400.50%-2,693.47%-
Inventory Turnover Ratio Ann.
-
-
--30.438.33927.724.510.4-
Asset Turnover Ann. %
-
-
--00.10.1000-
Working Capital Turnover Ann.
-
-
1.1-0.20.200.10-
Quick Ratio Ann.
38.7%
-37.4%
0.80.210.32.78.32.51.213.9
Current Ratio Ann.
10.1%
-38%
0.80.21.20.62.98.732.415.2
Interest Coverage Ratio Ann.
-
-
-11.2----288.721.2---
LT Debt To Equity Ann.
-
-
-0.100.10.4-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Current Ratio Ann.
1Y CHG
300%
2Y CAGR
-18.4%
3Y CAGR
10.1%
5Y CAGR
-38%
7Y CAGR
-14.5%
Current Ratio Annual growth is higher than historical averages.

Niki BioSolutions Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Niki BioSolutions Inc Cash From Operating Activity is $-2 Million which is growth of -54.4% YoY.

  • POSITIVE

    Net Cash Flow Niki BioSolutions Inc Net Cash Flow is $3 Million which is growth of 328.0% YoY.

Niki BioSolutions Inc., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17
⌄
-
-
-1.8-1.2-7.7-12.3-14.7-15.9-13.4-10-
⌄
-81.8%
-
0.10.62.416.51.8-0.1-6.1-
⌄
-12.6%
-18.7%
4.44.16.62.812.4-7.325.5-
Cash Plus Cash Eqv. End Of Year Ann.
-11.2%
-0.6%
3.50.9258.33.65.326.1-
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
2.6-1.1-3-3.34.6-1.7-20.89.4-
Cash Plus Cash Eqv. Begin Of Year Ann.
-52.3%
-29.9%
0.9258.33.65.326.116.7-
Income Tax Paid Supplemental Data Ann.
-
-
--
Interest Paid Supplemental Data Ann.
-
-
0.10.10.30.10.60.6-
Capex Ann.
-
-
---0.2-0.1-0.2-1.1-6.1-
Issuance Of Capital Stock Ann.
-
-21.9%
5.11.60417.511.1-
Issuance Of Debt Ann.
-
-
5.56.53.516.1-
Repayment Of Debt Ann.
-
-
-3-0.1-5.5-5.4-13.7-0.1-
Repurchase Of Capital Stock Ann.
-
-
---------
Free Cash Flow Ann.
-
-
-1.8-1.2-7.7-12.5-14.8-16.1-14.5-16.1-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Investing Act. Ann.
1Y CHG
-83.3%
2Y CAGR
-79.6%
3Y CAGR
-81.8%
Cash from Financing Act. Ann.
2Y CAGR
3.6%
3Y CAGR
-12.6%
5Y CAGR
-18.7%
7Y CAGR
-22.2%
Cash from Financing Annual Activity growth is higher than historical averages.
×